Issued Patents All Time
Showing 1–25 of 59 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12383521 | Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists | Roshantha A. Chandraratna, Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle | 2025-08-12 |
| 12325685 | RXR agonist salt form, polymorphs thereof, and uses thereof | Vidyasagar Vuligonda, Shanming Kuang, Harsh Shah | 2025-06-10 |
| 12324827 | Combination therapy for the treatment of migraines | Richard Kraig, Lisa Won, Kae M. Pusic, Aya Pusic | 2025-06-10 |
| 12115193 | Methods of using RARγ agonists for cancer treatment | Vidyasagar Vuligonda | 2024-10-15 |
| 11998521 | Use of an RXR agonist in treating drug resistant HER2+ cancers | Powel H. Brown, Cassandra Moyer, Abhijit Mazumdar | 2024-06-04 |
| 11919848 | RXR agonist salt form, polymorphs thereof, and uses thereof | Vidyasagar Vuligonda, Shanming Kuang, Harsh Shah | 2024-03-05 |
| 11896558 | Use of an RXR agonist and taxanes in treating Her2+ cancers | Powel H. Brown, Cassandra Moyer, Abhijit Mazumdar | 2024-02-13 |
| 11793835 | Methods of using RARγ agonists for cancer treatment | Vidyasagar Vuligonda | 2023-10-24 |
| 11786555 | RAR selective agonists in combination with immune modulators for cancer immunotherapy | Roshantha A. Chandraratna | 2023-10-17 |
| 11779558 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Roshantha A. Chandraratna | 2023-10-10 |
| 11737996 | Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Roshantha A. Chandraratna | 2023-08-29 |
| 11690832 | Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones | Roshantha A. Chandraratna | 2023-07-04 |
| 11690831 | Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones | Roshantha A. Chandraratna | 2023-07-04 |
| 11648223 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Roshantha A. Chandraratna | 2023-05-16 |
| 11517549 | Treatment of disease with esters of selective RXR agonists | Roshantha A. Chandraratna | 2022-12-06 |
| 11224583 | Use of an RXR agonist in treating HER2+ cancers | Powel H. Brown | 2022-01-18 |
| 11065219 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Roshantha A. Chandraratna | 2021-07-20 |
| 10987330 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Roshantha A. Chandraratna | 2021-04-27 |
| 10980760 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Roshantha A. Chandraratna | 2021-04-20 |
| 10980759 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Roshantha A. Chandraratna | 2021-04-20 |
| 10980761 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Roshantha A. Chandraratna | 2021-04-20 |
| 10973791 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Roshantha A. Chandraratna | 2021-04-13 |
| 10966950 | Use of an RXR agonist in treating HER2+ cancers | Powel H. Brown | 2021-04-06 |
| 10946001 | Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones | Roshantha A. Chandraratna | 2021-03-16 |
| 10881628 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Roshantha A. Chandraratna | 2021-01-05 |